A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

检 索： 期刊全称 刊名关键词 ISSN         高级检索

期刊名称：AIDS PATIENT CARE AND STDS ISSN： 1087-2914 出版频率： Monthly 出版社： MARY ANN LIEBERT, INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801   出版社网址： http://www.liebertpub.com/ 期刊网址： http://www.liebertpub.com/apc 影响因子： 5.078 (2020年) 3.742(2018年) 4.041(2017年) 3.236(2016年) 3.578(2015年) 3.497(2014年) 3.576(2013年) 3.090 (2012年) 2.411(2011年) 主题范畴： PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal AIDS Patient Care and STDs is the foremost journal providing the latest developments and research in diagnostics and therapeutics designed to prolong the lifespan and improve quality of life for HIV/AIDS patients. The Journal delivers cutting-edge clinical, basic science, sociologic, and behavior-based investigations in HIV/AIDS and other sexually transmitted infections. Clinical trials, quantitative and qualitative analyses of pilot studies, comprehensive reviews, and case reports are presented from leading experts and scientists around the world. AIDS Patient Care and STDs coverage includes: Prominent AIDS medications, therapies, and antiretroviral agents HIV/AIDS-related diseases, infections, and complications Challenges of medication adherence Current prevention techniques for HIV The latest news and developments on other STDs Treatment/prevention options, including pre- and post-exposure prophylaxis AIDS Patient Care and STDs is under the editorial leadership of Editor-in-Chief Jeffrey Laurence, MD, Weill Cornell Medical College, Laboratory for AIDS Virus Research at New York Blood Center; Senior Consulting Editor Robert C. Gallo, MD, Institute of Human Virology, University of Maryland School of Medicine; and other leading investigators. View the entire editorial board. Audience: HIV/AIDS clinicians, nurses, and psychologists; behavioral and social scientists; infectious disease specialists; immunologists; pathologists; virologists; hospital and AIDS treatment facility staff; and municipal health department staff; among others. Indexed/Abstracted in: MEDLINE; PubMed; PubMed Central; Current Contents®/Social & Behavioral Sciences; Science Citation Index Expanded; Social Sciences Citation Index®; Social SciSearch®; Journal Citation Reports/Science Edition; Journal Citation Reports/Social Sciences Edition; Derwent Drug File; EMBASE/Excerpta Medica; Scopus; CINAHL® database; ProQuest; PsycINFO; CAB Abstracts; Global Health; British Nursing Index; AMED - Allied and Contemporary Medicine Database . Instructions to Authors Mary Ann Liebert, Inc. Submission Benefits Package Your submission to AIDS Patient Care and STDs provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive: Complimentary 12-month AuthorCite™ membership Exclusively licensed by Mary Ann Liebert, Inc., AuthorCite™ delivers a 360-degree view of your article from submission to publication to market impact. With an AuthorCite™ membership, you’ll receive end-to-end manuscript submission tracking, a custom online microsite to promote you and your research, a professional suite of metrics and analytics to measure the impact of your article, 30-day OpenLink™ article sharing, and much more. Rapid, rigorous peer-review and editorial attention Immediate deposit to PubMed and other indexing services upon online publication Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads Fast Track online-ahead-of-print publication Global availability in over 170 countries Open Access publication options Submitting Your Manuscript Submitting your manuscript to AIDS Patient Care and STDs delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. This includes a one-year membership to AuthorCite™, a robust author services platform for increasing the visibility of your research, and includes the ability to freely share your article for 30 days. AIDS Patient Care and STDs carries a manuscript processing charge* of $50.00 USD upon submission of each new manuscript. Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system.  Please note:  Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission. Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges. Click here to submit your paper via our fast and user-friendly electronic submission system. Manuscript Revisions Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/aidspatientcare and click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code. Please be sure to follow the Instructions for Authors below on Manuscript Preparation.  Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge.   *The manuscript processing charge is independent of editorial decision and is non-refundable. Preparation of Manuscript Be sure these instructions are followed exactly.   We welcome contributions on topics of major significance in biotherapy, radiopharmaceuticals, and related fields that may be of the following types: (1) Reviews; (2) Research Papers; and (3) Short Communications. Each coauthor accepts responsibility for the entire contents of the manuscript. Contributions to the journal are published at no charge to the author. Once a paper has been accepted for publication, it cannot be withdrawn.   Authors will have the option to indicate one reviewer who should be excluded (non-preferred) from review of their manuscript.   Authors will also have the option to suggest preferred reviewers during the submission process if they like.   Abstracts ABSTRACT should be capitalized and centered on the page and have one space below. The text of the abstract is single spaced and should be limited to 200 words. This should appear on a separate page. Key words Please provide a short list of key words to follow the Abstract.  You will also be asked to enter keywords during online submission. Tables and Figures Each table should be prepared in a separate file. Tables should be cited in the text (see Table 1). Tables should be submitted in Microsoft Word.   Each figure should be prepared in a separate file with the figure number visible. Each figure should be cited in text (Fig. 1). Legends should be on a separate page from the figures.   Please follow these guidelines for submitting figures:  Do NOT embed art files into a Word or PDF document. Line illustrations should be submitted at 1200 dpi. Halftones and color should be submitted at a minimum of 300 dpi. Save as either TIFF or EPS files. Color art must be saved as CYMK – not RGB. Black and White art must be submitted as grayscale – not RGB. Do NOT submit PowerPoint, PDF, Bitmap or Excel files. Please name your artwork files with the submitting author's name i.e. SmithFig1.tif, SmithTable2.tif etc. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)  Authors who do not follow these guidelines may have their submission returned to them without being reviewed. You will be given directions on how to correct any files which do not pass. ADDITIONAL INFORMATION ABOUT ART FILES   Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the guidelines below :   All files should be scanned at 100% size. 300 dpi Final color mode: cmyk save file as: .tif or .eps If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf Footnotes Footnotes should be typed single spaced at the bottom of the appropriate page and separated from the text by a 3-inch line starting from the left margin with one space above and below it. Footnotes should be used only when essential. Acknowledgments Collaborations, sources of research funds, and other acknowledgments must be listed in a separate section at the end of the text ahead of the REFERENCES section. AUTHOR DISCLOSURE All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section. References Cite references within the text by a superscripted Arabic number as in the following example: [. . .as described previously. 1,4 ]. List references by number (1, 2, etc.) in the order in which they appear in the text. Type single spaced, although separated from each other by one line of space. Use Chemical Abstracts format for references. For journal citations: (1) surname of author(s) and initials; (2) title of article; (3) journal; (4) volume number; (5) first page of citation; and (6) year in parentheses. For book citations: (1) surname of author(s) and initials; (2) title of book; (3) editor of book (if applicable); (4) edition of book (if applicable); (5) publisher; (6) city of publication; (7) year of publication (not in parentheses); and (8) page reference (if applicable). For book and journal references, if there are more than four authors, list only the first three, followed by et al. For patents: (1) country of original registration; (2) patent number; and (3) month, day, and year of issuance. When data from an unpublished source are given, supply complete information (e.g., researcher’s name and location). If work is in press, give journal in which it is to be published or publisher. IMPORTANT Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded onto Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process. Permissions Written permission to use copyrighted material must be obtained from the publisher (not the author or editor). The publication from which the figure, table, or text is taken must be listed in REFERENCES. Finally, the first footnote of a reprinted table, or the last sentence of the legend of a reprinted figure, should read “reprinted by permission from Ref. (00),” using appropriate reference number. All permissions must be listed. Correspondence Be sure to provide the complete name and address to which correspondence should be directed. Disclosures Funding sources for research must be disclosed for all manuscripts accepted for publication. Reprints Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate. Publisher The Journal is published 12 times per year by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; fax: (914) 740-2101; e-mail: info@liebertpub.com ; online: www.liebertpub.com. Editorial Board Editor-in-Chief Jeffrey Laurence, M.D. Director, Laboratory for AIDS Virus Research Weill Medical College of Cornell University 411 East 69th Street New York, NY 10021 Tel. (212) 746-2988 Fax (212) 746-8601 Senior Consulting Editor Robert C. Gallo, M.D. Institute of Human Virology University of Maryland at Baltimore 725 West Lombard Street Baltimore, MD 21201 Associate Editors Kenneth Mayer, M.D. Brown University School of Medicine and The Miriam Hospital Providence, RI Julio Montaner, M.D. St. Paul's Hospital University of British Columbia Vancouver, BC, Canada William G. Powderly, M.D. Mater Misericordiae University Hospital University College Dublin Dublin, Ireland Editorial Board David Bangsberg, M.D., M.P.H. San Francisco General Hospital San Francisco, CA Lori Fantry, M.D., M.P.H. Institute of Human Virology University of Maryland at Baltimore Baltimore, Maryland Margaret Fischl, M.D. University of Miami Miami, FL Marshall Glesby, M.D., Ph.D. Weill Medical College of Cornell University New York, NY Jeffrey D. Klausner, M.D., M.P.H. University of California at San Francisco San Francisco, CA H. Clifford Lane, M.D. NIAID/NIH Bethesda, MD Jay A. Levy, M.D. University of California at San Francisco San Francisco, CA John E. Roberts, Ph.D. SUNY at Buffalo Buffalo, NY Alice Rosenberg, R.N. National Institutes of Health Bethesda, MD Victoria Sharp, M.D. St. Luke's-Roosevelt Hospital Center New York, NY David Simpson, M.D. Neuro-AIDS Research Mount Sinai Medical Center New York, NY Daniel J.M. Tarantola, M.D. Senior Policy Advisor to the Director General World Health Organization Geneva, Switzerland